Welcome to our dedicated page for Icu Medical SEC filings (Ticker: ICUI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Infusion pumps, needle-free connectors, and critical-care sensors keep ICU Medical at the heart of patient safety—and make its SEC disclosures rich with product detail and regulatory nuance. If you have ever searched for “ICU Medical SEC filings explained simply” or needed the exact numbers behind its consumable margins, you know a 300-page 10-K can feel overwhelming.
Stock Titan’s AI-powered summaries turn those dense filings into clear insights. Whether you are comparing segments in the ICU Medical annual report 10-K simplified, tracking real-time ICU Medical Form 4 insider transactions, or skimming an ICU Medical 8-K material events explained alert on a product recall, our platform highlights what matters and why. We cover every form—10-Q, 10-K, 8-K, DEF 14A, and S-8—seconds after they hit EDGAR, so you never wait for updates.
Looking for practical answers? Use our AI to locate supply-chain risk disclosures in the next ICU Medical quarterly earnings report 10-Q filing; monitor board-level pay from the latest ICU Medical proxy statement executive compensation; or set alerts for ICU Medical executive stock transactions Form 4. Investors rely on these features to spot insider sentiment, gauge FDA compliance, and compare acquisition integration costs quarter over quarter. Stop scrolling through hundreds of pages—our expert analysis and machine learning surface the data points that drive decisions.
Vivek Jain, Chairman and CEO of ICU Medical, reported a Form 4 disclosing transactions dated 09/12/2025. The filing shows a gift of 63,641 shares of common stock to two trusts established for family members who share the same household; the reporting person disclaims beneficial ownership of the shares held by those trusts. After the reported transactions, Mr. Jain retained 66,508 shares directly and the trusts hold 152,339 shares indirectly. The form was signed by an attorney-in-fact on 09/15/2025.
David C. Greenberg, a director of ICU Medical, Inc. (ICUI), reported open-market purchases on 08/27/2025. The Form 4 shows two non-derivative purchases: 602 shares at a weighted-average price of $126.1428, bringing his direct beneficial ownership to 7,362 shares, and 598 shares at a weighted-average price of $126.6895, bringing his direct beneficial ownership to 7,960 shares. The filing also discloses 500 shares held indirectly by a trust. The purchases were executed in multiple transactions within the disclosed price ranges; the filer offers to provide detailed per-transaction pricing on request.
Vivek Jain, Chairman and CEO of ICU Medical, Inc. (ICUI), reported purchases of company common stock on 08/14/2025. He acquired 2,378 shares at a weighted-average price of $112.1165 (purchases ranged $111.75–$112.435) and 19,551 shares at a weighted-average price of $112.9232 (purchases ranged $112.48–$113.435). Following these transactions, Mr. Jain beneficially owns 130,149 shares directly and 88,698 shares indirectly through a trust; a prior direct holding of 110,598 shares is shown prior to the second reported purchase line. The Form 4 was signed by an attorney-in-fact, Paula Darbyshire.
Janus Henderson Group plc and an affiliated fund reported beneficial ownership stakes in ICU Medical, Inc. Janus Henderson Group plc is shown with shared voting and dispositive power over 2,470,146 common shares, equal to 10.0% of the class. Janus Henderson Enterprise Fund reports shared voting and dispositive power over 1,230,753 shares, equal to 5.0% of the class. The filing also notes that JHIUS may be deemed beneficial owner of 2,411,637 shares ( 9.8% ) with shared voting and dispositive authority.
The filing includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. Power of attorney and signature attestations are included, identifying the compliance officer who signed on behalf of the reporting entities.
ICU Medical registered 2,150,000 shares of its common stock for issuance under the Third Amendment to its Amended and Restated 2011 Stock Incentive Plan, approved by stockholders at the 2025 annual meeting on May 13, 2025. The filing confirms these additional shares are the same class as prior awards and incorporates earlier Form S-8 and 10-K registrations by reference, and includes related exhibits and legal opinions.
FAQ
What is the current stock price of Icu Medical (ICUI)?
What is the market cap of Icu Medical (ICUI)?
